XML 48 R41.htm IDEA: XBRL DOCUMENT v3.25.3
Strategic transactions and agreements - Zentalis Pharmaceuticals (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Oct. 25, 2024
Jan. 05, 2024
Mar. 31, 2024
Zentalis Asset Purchase Agreement      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Issuance of common stock     $ 23,388
Number of shares issued 1,805,502    
Common stock issued $ 21,000    
Share Price $ 12.11    
Percentage of discount related to unregistered share restrictions to be deducted from the share price 4.00%    
Cash upon the achievement of a developmental milestone $ 5,000    
License agreement with Zentalis Pharmaceuticals, Inc      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
License Agreement, Upfront Payment in Cash   $ 15,000  
Shares issued   2,298,586  
Issuance of common stock   $ 23,400  
Share Price   $ 11.12  
Percentage of discount related to unregistered share restrictions to be deducted from the share price   8.50%  
Transaction cost   $ 200